D.N.A. Biomedical Solutions Aktie

D.N.A. Biomedical Solutions für 0 Euro bei ZERO ordern (zzgl. Spreads)

ISIN: IL0011038523

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
18.09.2023 13:23:03

Ginkgo Bioworks, Factorial Join To Develop Enzyme For Single-Cell Library Prep Technology

(RTTNews) - Factorial Biotechnologies and Ginkgo Bioworks (DNA) announced a collaboration, through which, Factorial will leverage Ginkgo Enzyme Services to develop an isothermal DNA polymerase for use in Factorial's single-cell next-generation sequencing library prep kit. Ginkgo is providing the services under its success-based pricing model, created to help companies de-risk their research and development efforts.

Ginkgo Bioworks is a horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Based in San Carlos, California, Factorial Biotechnologies is an emerging single-cell sequencing company developing an in-cell library preparation technology.

For More Such Health News, visit rttnews.com.

Nachrichten zu D.N.A. Biomedical Solutions Ltd.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu D.N.A. Biomedical Solutions Ltd.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!